LIPFENDRA enlicitide First Oral PCSK9 Inhibitor to Lower LDL "Bad" Cholesterol

The FDA just approved LIPFENDRA (enlicitide) — the first-ever ORAL PCSK9 inhibitor, approved to lower LDL (“bad”) cholesterol in adults with high cholesterol or heterozygous familial hypercholesterolemia (HeFH). For nearly a decade, PCSK9 inhibitors have only existed as injections. That just changed. In this #FDAFridays breakdown, we cover: ✅ What “bad” cholesterol (LDL-C) actually does to your arteries and heart ✅ What PCSK9 is and how blocking it lowers LDL ✅ The trial data behind the approval — up to 59% greater LDL-C reduction vs. placebo ✅ Safety and tolerability findings from both pivotal trials ✅ Why an oral option is a big deal for long-term adherence 📊 THE DATA Two randomized, double-blind, placebo-controlled trials (NCT05952856 and NCT05952869) enrolled 3,207 adults with severe hypercholesterolemia already on maximally tolerated statin therapy. • Trial 1 (ASCVD/high-risk patients): -56% LDL-C vs. placebo at Week 24 • Trial 2 (HeFH patients): -59% LDL-C vs. placebo at Week 24 💊 ABOUT LIPFENDRA LIPFENDRA is a once-daily oral tablet, used together with diet and exercise, to reduce LDL-C in adults with high cholesterol or HeFH. 🔔 Subscribe to Drug Insight Hub for plain-English breakdowns of new FDA approvals every #FDAFridays. #LIPFENDRA #enlicitide #PCSK9 #cholesterol #LDL #FDAapproval #FDAFridays #pharma #Merck #hypercholesterolemia #heartdisease #DrugInsightHub Disclaimer: The content in this video is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. I am not a licensed medical doctor, pharmacist, or healthcare provider. Do not use this information to self-diagnose or make any changes to your medication, diet, or health regimen without first consulting a qualified healthcare professional. Always seek the advice of your physician or another licensed health provider with any questions you may have regarding a medical condition. While every effort has been made to ensure the accuracy and reliability of the information provided, I make no guarantees and assume no responsibility for errors or omissions. Any action you take based on the content of this video is strictly at your own risk. I will not be held liable for any loss or damage arising from your reliance on this information.